» Articles » PMID: 17158772

History of Treated Hypertension and Diabetes Mellitus and Risk of Renal Cell Cancer

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2006 Dec 13
PMID 17158772
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An increased risk of renal cell cancer (RCC) has been reported in subjects with hypertension. Whether this association may vary according to sex, smoking, obesity, or RCC clinical presentation is unclear. Results on the link between diabetes mellitus and RCC are inconclusive.

Patients And Methods: We conducted an Italian multicenter case-control study, including 767 (494 men, 273 women) incident cases of RCC, under 80 years of age, and 1534 hospital controls, frequency-matched to cases. Multiple logistic regression models, conditioned to center, sex, and age, and adjusted for period of interview, education, smoking, and body mass were used to estimate odds ratios (OR).

Results: Compared with subjects never treated, patients with a history of treated hypertension [OR = 1.7, 95% confidence interval (CI) 1.4-2.1] reported an excess risk of RCC. This pattern was confirmed in different strata of sex, education, smoking habits, body mass, tumor histological type, stage, or grade. The attributable risk of RCC for treated hypertension in this population was 16%. A slight, nonsignificant increased risk was found for history of diabetes mellitus (OR = 1.3, 95% CI 0.9-1.7).

Conclusion: A possible causal role of hypertension in renal cell carcinogenesis is supported by the consistency of the direct association.

Citing Articles

Legume intake and cancer risk in a network of case-control studies.

Patel L, La Vecchia C, Negri E, Mignozzi S, Augustin L, Levi F Eur J Clin Nutr. 2024; 78(5):391-400.

PMID: 38321187 DOI: 10.1038/s41430-024-01408-w.


The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC.

Liu Y, Wu G Front Immunol. 2023; 14:1276658.

PMID: 38090562 PMC: 10715415. DOI: 10.3389/fimmu.2023.1276658.


Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions.

Jani C, Abdallah N, Mouchati C, Jani R, Sharma R, Bhatt P Sci Rep. 2022; 12(1):22368.

PMID: 36572700 PMC: 9792551. DOI: 10.1038/s41598-022-25485-8.


The relationship between urologic cancer outcomes and national Human Development Index: trend in recent years.

Xia X, Wang Y, Shao S, Zhao X, Zhang S, Li Z BMC Urol. 2022; 22(1):2.

PMID: 35012527 PMC: 8744298. DOI: 10.1186/s12894-022-00953-5.


The Role of Metabolic Factors in Renal Cancers.

Rysz J, Franczyk B, Lawinski J, Olszewski R, Gluba-Brzozka A Int J Mol Sci. 2020; 21(19).

PMID: 33008076 PMC: 7582927. DOI: 10.3390/ijms21197246.